Results 161 to 170 of about 10,975 (245)

Cholinergic Crisis Associated With Standard-Dose Pyridostigmine in a Hemodialysis Patient With Ocular Myasthenia Gravis and Marked Weight Loss. [PDF]

Cureus
Junki K, Nozaki Y, Miyake K.
europepmc   +1 more source

Thymectomy in ocular myasthenia gravis-prognosis and risk factors analysis. [PDF]

Orphanet J Rare Dis, 2022
Zhang J, Zhang Z, Zhang H, Cui Y, Chen Y, Lv P, Zhang P.   +6 more
europepmc   +1 more source

Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis

, 2022
Jie Rao, Siyu Li, Xinyu Wang, Qi Cheng, Yu Ji, Wenwen Fu, Hui Huang, Ling Shi, Xiaorong Wu   +8 more
openalex   +1 more source

Robotic thymectomy for ocular myasthenia gravis: a case series from a UK tertiary centre. [PDF]

BMJ Neurol Open
Roberts T, Cone S, Spillane J, Lawrence D, Maraschi A, Bhakhri K.   +5 more
europepmc   +1 more source

The Role of Thymoma and Thymic Hyperplasia as Prognostic Risk Factors for Secondary Generalisation in Adults with Ocular Myasthenia Gravis: A Systematic Narrative Review. [PDF]

Br Ir Orthopt J, 2023
Wilson L, Davis H.
europepmc   +1 more source

Thymectomy in ocular myasthenia gravis before generalization results in a higher remission rate [PDF]

, 2019
Feng Li, Zhongmin Li, Yanli Chen, Gero Bauer, Deniz Uluk, Aron Elsner, Marc Swierzy, Mahmoud Ismail, Andreas Meisel, Jens-C. Rückert   +9 more
openalex   +1 more source

Ocular myasthenia gravis saccades as a measure of extraocular muscle function. [PDF]

Front Ophthalmol (Lausanne), 2022
Wong SH, Bancroft MJ, Tailor VK, Abbas M, Sekar A, Noble C, Theodorou M, Kaski D.   +7 more
europepmc   +1 more source

Thymectomy in Ocular Myasthenia Gravis: Results Before and After Generalization and Prognostic Predictors of Outcomes. [PDF]

J Clin Med
Nachira D, Congedo MT, Kuzmych K, Evoli A, Iorio R, Vita ML, Petracca-Ciavarella L, Nocera A, Sassorossi C, Evangelista J, Lyberis P, Comacchio GM, Brandolini J, Aprile V, Zifara CC, Mastromarino MG, Patirelis A, Asteggiano E, Anile M, Venuta F, Imperatori A, Ambrogi V, Solli P, Dell'Amore A, Lucchi M, Melfi F, Ibrahim M, Ruffini E, Rea F, Margaritora S, Meacci E.   +30 more
europepmc   +1 more source

Commentary: Ocular myasthenia gravis: Interpreting the investigations. [PDF]

Indian J Ophthalmol, 2022
Nair AG.
europepmc   +1 more source

Low-dose rituximab in AChR antibody-positive ocular myasthenia gravis: Efficacy and safety-A preliminary study. [PDF]

Medicine (Baltimore)
Mao B, Wang R, Liu X, Ping D, Xu Y, Ning L.   +5 more
europepmc   +1 more source